Literature DB >> 16099868

T cell-induced inflammation of the small and large intestine in immunodeficient mice.

Dmitry V Ostanin1, Kevin P Pavlick, Sulaiman Bharwani, Dwain D'Souza, Kathryn L Furr, Carla M Brown, Matthew B Grisham.   

Abstract

It is well known that transfer of CD4+CD45RBhigh (naïve) T cells into syngeneic lymphocyte-deficient mice induces chronic colitis. However, no studies have reported the presence of small bowel inflammation in this T cell-dependent model. Therefore, the objective of this study was to evaluate and compare small and large bowel inflammation induced by transfer of naïve T cells into two different immunodeficient recipient mice. T and B cell-deficient recombinase activating gene 1-deficient [RAG knockout (KO)] and T cell-deficient T cell receptor-beta x T cell receptor-delta double-deficient (TCR KO) mice were reconstituted with wild-type naïve T cells and observed for signs of disease. We found that reconstituted RAG KO mice developed moderate to severe colitis and inflammation of the entire small intestine at 6-8 wk after T cell transfer. Adoptive transfer of naïve T cells into TCR KO mice induced a milder form of chronic colitis and small bowel inflammation that was confined primarily to the duodenum at 10-12 wk after T cell transfer. T helper cell 1 and macrophage-derived proinflammatory cytokine mRNA levels correlated well with the localization and severity of the chronic large and small bowel inflammation. In addition, we observed comparable homing and expansion of donor lymphocytes in the gut and secondary lymphoid tissues of both recipients. Taken together, our data demonstrate that transfer of naïve T cells into immunodeficient recipient mice induces both chronic small and large bowel inflammation and that the presence of B cells in the TCR KO recipients may play a role in regulating chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099868     DOI: 10.1152/ajpgi.00214.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  39 in total

1.  Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.

Authors:  Robert Barrett; Xiaolan Zhang; Hon Wai Koon; Michelle Vu; Jyh-Yau Chang; Nicole Yeager; Mary Ann Nguyen; Kathrin S Michelsen; Dror Berel; Charalabos Pothoulakis; Stephan R Targan; David Q Shih
Journal:  Am J Pathol       Date:  2011-12-02       Impact factor: 4.307

2.  Evaluation of the immunoregulatory activity of intraepithelial lymphocytes in a mouse model of chronic intestinal inflammation.

Authors:  D V Ostanin; C M Brown; L Gray; S Bharwani; M B Grisham
Journal:  Int Immunol       Date:  2010-11-11       Impact factor: 4.823

Review 3.  The Role of Neuropeptides in Mouse Models of Colitis.

Authors:  David Padua; John P Vu; Patrizia M Germano; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2015-12-08       Impact factor: 3.444

Review 4.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

Review 5.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

6.  Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells.

Authors:  Sophie Laffont; Karima R R Siddiqui; Fiona Powrie
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

7.  Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis.

Authors:  Dmitry V Ostanin; Elvira Kurmaeva; Katie Furr; Richard Bao; Jason Hoffman; Seth Berney; Matthew B Grisham
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

8.  Spontaneous, immune-mediated gastric inflammation in SAMP1/YitFc mice, a model of Crohn's-like gastritis.

Authors:  Brian K Reuter; Luca Pastorelli; Marco Brogi; Rekha R Garg; James A McBride; Robert M Rowlett; Marie C Arrieta; Xiao-Ming Wang; Erik J Keller; Sanford H Feldman; James R Mize; Fabio Cominelli; Jonathan B Meddings; Theresa T Pizarro
Journal:  Gastroenterology       Date:  2011-06-23       Impact factor: 22.682

9.  Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis.

Authors:  Koichi Takebayashi; Iurii Koboziev; Dmitry V Ostanin; Laura Gray; Fridrik Karlsson; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; Angela Burrows Dooley; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

10.  Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.

Authors:  F L Scott; B Clemons; J Brooks; E Brahmachary; R Powell; H Dedman; H G Desale; G A Timony; E Martinborough; H Rosen; E Roberts; M F Boehm; R J Peach
Journal:  Br J Pharmacol       Date:  2016-04-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.